









Markets
/
Stocks
/
nasdaq-hum
/

Humana Inc

HUM

278.170USD

-7.440-2.60%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

33.46BMarket Cap

21.23P/E TTM



Humana Inc

278.170

-7.440-2.60%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Humana Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Humana Inc's Score

Industry at a Glance

Industry Ranking

36 / 78

Overall Ranking

173 / 4621

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 29 analysts

Hold

Current Rating

293.421

Target Price

+0.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Humana Inc Highlights

StrengthsRisks

Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 26.80% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 35.63%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 35.63%.

Fairly Valued

The company’s latest PE is 21.83, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 115.83M shares, decreasing 7.70% quarter-over-quarter.

Held by Richard Pzena

Star Investor Richard Pzena holds 4.08M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 4.87, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 32.39B, representing a year-over-year increase of 9.64%, while its net profit experienced a year-over-year increase of 19.73%.

Score

Industry at a Glance

Previous score

4.87

Change



Financials

5.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.29

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

4.63

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.73

Key Metrics

Free cash flow

No Data

Humana Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 6.75, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 21.83, which is 38.68% below the recent high of 30.28 and 27.97% above the recent low of 15.73.

Score

Industry at a Glance

Previous score

6.75

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 36/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 6.86, which is lower than the Healthcare Providers & Services industry's average of 7.60. The average price target for Humana Inc is 292.50, with a high of 347.00 and a low of 235.00.

Score

Industry at a Glance

Previous score

6.86

Change

Support & Resistance

No Data

Analyst Rating

Based on 29 analysts

Hold

Current Rating

293.421

Target Price

+2.73%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Humana Inc

HUM

UnitedHealth Group Inc

UNH

Cigna Group

Elevance Health Inc

ELV

Centene Corp

CNC

Molina Healthcare Inc

MOH

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 8.73, which is higher than the Healthcare Providers & Services industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 307.26 and the support level at 259.49, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.23

Change

-0.5

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.056

Buy

RSI(14)

47.884

Neutral

STOCH(KDJ)(9,3,3)

32.562

Sell

ATR(14)

8.996

Low Volatility

CCI(14)

-8.368

Neutral

Williams %R

49.988

Neutral

TRIX(12,20)

0.269

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

288.722

Sell

MA10

289.248

Sell

MA20

284.443

Sell

MA50

281.241

Sell

MA100

264.064

Buy

MA200

262.790

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 96.30%, representing a quarter-over-quarter increase of 0.93%. The largest institutional shareholder is The Vanguard, holding a total of 14.14M shares, representing 11.76% of shares outstanding, with 11.03% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

14.14M

+1.60%

Dodge & Cox

Star Investors

11.35M

+5.56%

BlackRock Institutional Trust Company, N.A.

6.28M

-4.97%

State Street Investment Management (US)

5.38M

+1.09%

Pzena Investment Management, LLC

Star Investors

4.08M

+6.47%

Eagle Capital Management L.L.C.

3.95M

+25.65%

Geode Capital Management, L.L.C.

3.13M

+1.86%

Fidelity Management & Research Company LLC

2.61M

+24.72%

Sessa Capital

2.12M

+458.42%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 6.45, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.42. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.